Alexandra Bahgat
Chief Resident, Pediatrics
Credentials: ·
History
- 2023–2026
SUNY University of Buffalo
Research
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Nature Medicine · 2024 · 50 citations
- AM
1 paper
1 paper
- AK
1 paper
- AN
1 paper
- CT
1 paper
1 paper
- DW
1 paper
1 paper
